Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 498

Similar articles for PubMed (Select 17332509)

1.

Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma.

Shiras A, Chettiar ST, Shepal V, Rajendran G, Prasad GR, Shastry P.

Stem Cells. 2007 Jun;25(6):1478-89. Epub 2007 Mar 1.

2.

RADIATION RESPONSES OF STEM CELLS: TARGETED AND NON-TARGETED EFFECTS.

Kavanagh JN, Waring EJ, Prise KM.

Radiat Prot Dosimetry. 2015 Apr 15. pii: ncv161. [Epub ahead of print]

PMID:
25877536
3.

Hostile takeover: glioma stem cells recruit TAMs to support tumor progression.

Shi Y, Ping YF, Zhang X, Bian XW.

Cell Stem Cell. 2015 Mar 5;16(3):219-20. doi: 10.1016/j.stem.2015.02.008.

PMID:
25748928
4.

A niche role for periostin and macrophages in glioblastoma.

Squadrito ML, De Palma M.

Nat Cell Biol. 2015 Feb;17(2):107-9. doi: 10.1038/ncb3095.

PMID:
25633271
5.

Prognostic value of glioma cancer stem cell isolation in survival of primary glioblastoma patients.

Kong BH, Moon JH, Huh YM, Shim JK, Lee JH, Kim EH, Chang JH, Kim DS, Hong YK, Kim SH, Lee SJ, Kang SG.

Stem Cells Int. 2014;2014:838950. doi: 10.1155/2014/838950. Epub 2014 Dec 11.

6.

An in silico screen links gene expression signatures to drug response in glioblastoma stem cells.

Riddick G, Song H, Holbeck SL, Kopp W, Walling J, Ahn S, Zhang W, Fine HA.

Pharmacogenomics J. 2014 Dec 2. doi: 10.1038/tpj.2014.61. [Epub ahead of print]

PMID:
25446780
7.

Generation of murine xenograft models of brain tumors from primary human tissue for in vivo analysis of the brain tumor-initiating cell.

Qazi M, Mann A, van Ommeren R, Venugopal C, McFarlane N, Vora P, Singh SK.

Methods Mol Biol. 2014;1210:37-49. doi: 10.1007/978-1-4939-1435-7_4.

PMID:
25173159
8.

RESICstance is futile-but not in glioblastoma.

Zadeh G, Aldape K.

Cancer Cell. 2014 Aug 11;26(2):156-7. doi: 10.1016/j.ccr.2014.07.013.

PMID:
25117706
9.

Cancer stem cells on demand.

Nawy T.

Nat Methods. 2014 Jul;11(7):715. No abstract available.

PMID:
25110783
10.

Energy metabolism and metabolic sensors in stem cells: the metabostem crossroads of aging and cancer.

Menendez JA, Joven J.

Adv Exp Med Biol. 2014;824:117-40. doi: 10.1007/978-3-319-07320-0_10. Review.

PMID:
25038997
11.

Deletion of Ptp4a3 reduces clonogenicity and tumor-initiation ability of colitis-associated cancer cells in mice.

Cramer JM, Zimmerman MW, Thompson T, Homanics GE, Lazo JS, Lagasse E.

Stem Cell Res. 2014 Jul;13(1):164-71. doi: 10.1016/j.scr.2014.05.004. Epub 2014 May 27.

12.

Glioblastoma: Cancer stem cell knockout.

Seton-Rogers S.

Nat Rev Cancer. 2014 Jul;14(7):452-3. doi: 10.1038/nrc3771. Epub 2014 Jun 5. No abstract available.

PMID:
24898059
13.

Integrated analysis identifies different metabolic signatures for tumor-initiating cells in a murine glioblastoma model.

Saga I, Shibao S, Okubo J, Osuka S, Kobayashi Y, Yamada S, Fujita S, Urakami K, Kusuhara M, Yoshida K, Saya H, Sampetrean O.

Neuro Oncol. 2014 Aug;16(8):1048-56. doi: 10.1093/neuonc/nou096. Epub 2014 May 23.

PMID:
24860177
14.

A multicompartment mathematical model of cancer stem cell-driven tumor growth dynamics.

Weekes SL, Barker B, Bober S, Cisneros K, Cline J, Thompson A, Hlatky L, Hahnfeldt P, Enderling H.

Bull Math Biol. 2014 Jul;76(7):1762-82. doi: 10.1007/s11538-014-9976-0. Epub 2014 May 20.

15.

Connect four with glioblastoma stem cell factors.

Gronych J, Pfister SM, Jones DT.

Cell. 2014 Apr 24;157(3):525-7. doi: 10.1016/j.cell.2014.04.001.

16.

Aberrant self-renewal and quiescence contribute to the aggressiveness of glioblastoma.

Campos B, Gal Z, Baader A, Schneider T, Sliwinski C, Gassel K, Bageritz J, Grabe N, von Deimling A, Beckhove P, Mogler C, Goidts V, Unterberg A, Eckstein V, Herold-Mende C.

J Pathol. 2014 Sep;234(1):23-33. doi: 10.1002/path.4366. Epub 2014 Jul 10.

PMID:
24756862
17.

Human placenta-derived neurospheres are susceptible to transformation after extensive in vitro expansion.

Amendola D, Nardella M, Guglielmi L, Cerquetti L, Carico E, Alesi V, Porru M, Leonetti C, Bearzi C, Rizzi R, D'Agnano I, Stigliano A, Novelli G, Bucci B.

Stem Cell Res Ther. 2014 Apr 22;5(2):55. doi: 10.1186/scrt444.

18.

Cancer stem cell-specific scavenger receptor 36 drives glioblastoma progression.

Hale JS, Otvos B, Sinyuk M, Alvarado AG, Hitomi M, Stoltz K, Wu Q, Flavahan W, Levison B, Johansen ML, Schmitt D, Neltner JM, Huang P, Ren B, Sloan AE, Silverstein RL, Gladson CL, DiDonato JA, Brown JM, McIntyre T, Hazen SL, Horbinski C, Rich JN, Lathia JD.

Stem Cells. 2014 Jul;32(7):1746-58. doi: 10.1002/stem.1716.

19.

Glioma stem cells: turpis omen in nomen? (The evil in the name?).

Binda E, Reynolds BA, Vescovi AL.

J Intern Med. 2014 Jul;276(1):25-40. doi: 10.1111/joim.12254. Review.

PMID:
24708237
20.

Biphasic modulation of cancer stem cell-driven solid tumour dynamics in response to reactivated replicative senescence.

Poleszczuk J, Hahnfeldt P, Enderling H.

Cell Prolif. 2014 Jun;47(3):267-76. doi: 10.1111/cpr.12101. Epub 2014 Mar 25.

PMID:
24666838
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk